← Back to all trials
Completed
NCT07711782
Management of Polycystic Ovarian Syndrome-associated Reproductive Dysfunction Through Kefir Supplementation
Conditions: Polycystic Ovarian Syndrome (PCOS), Reproductive Health
Sex: Female
Ages: 18 Years – 25 Years
Healthy volunteers: No
Phase: NA
Enrollment: 50
Sponsor: University of Lahore
Location: The University of Lahore Lahore
Summary
Polycystic ovary syndrome (PCOS) affect around 6-12% of women of age 18-25 years. Kefir contains bioactive compounds such as lactic acid bacteria, yeast, peptides, polysaccharides and organic acids and acts as a good probiotic source.
Eligibility Criteria
Inclusion Criteria:
* Females of age 18-25 will be selected.
* Females suffering from amenorrhea or cycle longer then 35days were selected.
* Females with PCOS were selected.
* Females with BMI 18.5-29.9 were selected in this research.
* Females with thyroid issues were selected.
Exclusion Criteria:
* Pregnant and breast-feeding females were not included.
* Those who smoke were not included.
* Those who consume alcohol were not included.
* Those suffering from endocrine diseases were not be included.
* Those taking lipid- lowering drugs or blood pressure regulating medications were not be included.
* Those taking antibiotics or medications related to PCOS treatment or vitamin-mineral or probiotics within 1 month prior to study inclusion.
Source: ClinicalTrials.gov (NCT07711782). StuddyBuddy aggregates publicly available trial information.
